In vivo development of resistance to clindamycin by Staphylococcus aureus.
D000038:Abscess / Q000188:drug therapy; D000368:Aged; D001769:Blood / Q000382:microbiology; D002512:Cephalothin / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009254:Nafcillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D013210:Staphylococcus / Q000187:drug effects*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D013492:Suppuration / Q000382:microbiology
D002981:Clindamycin; D009254:Nafcillin; D002701:Chloramphenicol; D002512:Cephalothin